Biotronik on July 8 announced its BIOMONITOR III injectable cardiac monitor, a diagnostic tool designed to document suspected arrhythmias, has been cleared by the FDA.

The economic cost of the of lost earnings due to cancer deaths in the U.S. was more than $94 billion in 2015, according to a new study published in JAMA Oncology.

From the U.S. by way of the Land Down Under comes a “turbo-charged” flu vaccine created by AI.

While AI wasn’t the only topic discussed during the SIIM 2019 annual meeting, every issue seemed to be tied to the emerging technology in one way or another.

The Irish Hospital Consultants Association (IHCA) has launched a social media campaign, #CareCantWait, in response to a pervasive lack of access to medical care in the country.

While general support for a universal healthcare system remains at about 50% among the public, the impact to the healthcare industry is being weighed––and providers could see huge payment cuts under certain policies. 

A large-scale study of people living with HIV has linked the immune deficiency to an increased risk of CVD, in particular heart failure and stroke.

Heart patients of a lower socioeconomic status are far more likely to participate in cardiac rehabilitation if they receive financial incentives to attend sessions, according to a study published in the July 1 edition of JACC: Heart Failure.

It’s not unusual for hospitalized patients to take a sudden turn for the worse. A continuous inspection of electronic medical records by machine-learning algorithms can warn of impending trouble in real time, giving physicians a chance to proactively intervene.

Patients are worried about the rising cost of prescription drugs, and the high rate of cost growth has led lawmakers and the Trump administration to review steps to reduce runaway price growth. However, there are some ways for doctors to help patients avoid sticker shock on their prescriptions––and not many are using these tools, according to a report from NPR.